Artificial Intelligence

Improved Diagnostic Testing Boosts Patient Experience, Study Finds

by Samantha McGrail

Abbott recently released research from its multi-year global research program, which found that advancing diagnostic testing for vascular diseases can help hospitals and physicians improve the patient...

New Pilot to Leverage API, AI for Enhanced Diagnostic Accuracy

by Samantha McGrail

VisualDx and Janssen Biotech recently partnered to pilot a new application programming interface (API) and equitable artificial intelligence (AI) to enhance diagnostic accuracy.   The...

NHS Rolls Out 3D Imaging Technology for Heart Disease Diagnosis

by Samantha McGrail

NHS England recently announced that it is rolling out its 3D imaging technology, HeartFlow, to diagnose and treat nearly 1,000 patients with suspected heart disease. HeartFlow, part of NHS Long Term...

AI in the Pharma Industry: Current Uses, Best Cases, Digital Future

by Samantha McGrail

Pharmaceutical executives are looking for ways to leverage artificial intelligence and machine learning within the healthcare and the biotech industry. Reports show an increasing number of entities are...

Abbott Launches Artificial Intelligence-Powered Imaging Platform

by Samantha McGrail

Abbott recently announced that its artificial intelligence-powered,coronary imaging platform launched in Europe.  The platform, which is now CE marked in Europe, is the first-of-its-kind imaging...

FDA Approves Marketing of AI Medical Device to Detect Colon Cancer

by Samantha McGrail

FDA recently authorized marketing of the GI Genius, a medical device that uses artificial intelligence (AI) to assist clinicians in detecting signs of colon cancer.  GI Genius is based on machine...

Eli Lilly, Biolojic to Develop Antibody Therapies for Diabetes

by Samantha McGrail

Eli Lilly and Company and Biolojic Design recently announced a research agreement to discover and develop potential novel antibody therapies for the treatment of diabetes. The collaboration and...

Gauss, Cellex Launch First At-Home COVID-19 Antigen Test

by Samantha McGrail

Gauss and Cellex recently announced an exclusive partnership to launch the first-ever rapid, at-home COVID-19 antigen test. Once approved by FDA, the test would be the first to allow individuals to...

Study Identifies Potential Therapeutic COVID-19 Antibody

by Samantha McGrail

An antibody isolated from a patient who recovered from severe acute respiratory syndrome (SARS) in 2003 could be a potential therapeutic COVID-19 antibody, according to a study recently published in...

GSK, Vir Use CRISPR, Artificial Intelligence to Find COVID-19 Cure

by Samantha McGrail

GlaxoSmithKline (GSK) and Vir Biotechnology recently announced a collaboration to enhance COVID-19 drug discovery through the use of CRISPR and artificial intelligence. For more coronavirus updates,...

Machine Learning Moves the Needle on Personalized Antidepressants

by Ana Mulero

A machine learning algorithm can predict whether an individual is likely to benefit from sertraline treatment using a neural signature, findings published Monday in Nature Biotechnology...

GAO Backs Machine Learning in Drug Development

by Ana Mulero

The Government Accountability Office unveiled a report on Tuesday that identifies challenges and opportunities with the use of machine learning throughout the drug development lifecycle.  Machine...